:) if you ask nicely i might.Your right though Josh, these prices are a unique opportunity to lower your average, i didn't expect it and it's a bonus for me on my trading parcel re-enter.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%